ketanserin has been researched along with Femoral Fractures in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Femoral Fractures: Fractures of the femur.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skolnik, G | 1 |
| Ivarsson, L | 1 |
| Bagge, U | 1 |
1 other study available for ketanserin and Femoral Fractures
| Article | Year |
|---|---|
The influence of antiserotonin treatment with ketanserin on the pulmonary lodgement of circulating tumour cells in normal and traumatized rats.
Topics: Animals; Femoral Fractures; Fibrosarcoma; Ketanserin; Lung Neoplasms; Neoplasm Transplantation; Neop | 1983 |